ask="1.30"
ask_size="1800"
average_daily_volume="577353"
bid="1.25"
bid_size="2900"
book_value="1.37"
change="-0.95"
change_from_200_day_moving_average="-1.68"
change_from_50_day_moving_average="-1.11"
change_from_52_week_high="-7.60"
change_From_52_week_low="0.25"
change_in_percent="-42.22%"
close="1.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.31"
ebitda="-61.52M"
eps_estimate_current_year="-1.55"
eps_estimate_next_quarter="-0.38"
eps_estimate_next_year="-1.42"
ex_dividend_date="N/A"
float_shares="36032000"
high="1.50"
high_52_weeks="8.90"
last_trade_date="1/30/2017"
last_trade_price="1.30"
last_trade_size="12854"
last_trade_time="4:00pm"
low="1.05"
low_52_weeks="1.05"
market_capitalization="68.80M"
moving_average_200_day="2.98"
moving_average_50_day="2.41"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="8.60"
open="1.50"
pe_ratio="N/A"
peg_ratio="-0.04"
percent_change_from_200_day_moving_average="-56.39%"
percent_change_from_50_day_moving_average="-46.15%"
percent_change_from_52_week_high="-85.39%"
percent_change_from_52_week_low="+23.81%"
previous_close="2.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.64"
price_per_sales="9.89"
revenue="12.04M"
shares_outstanding="52923000"
short_ratio="4.28"
stock_exchange="NGM"
symbol="RGLS"
volume="8128743"
weeks_range_52="1.05 - 8.90"
